AI assistant
VIYASH SCIENTIFIC LIMITED — Call Transcript 2025
Aug 5, 2025
62287_rns_2025-08-05_88bb7824-1008-4b0a-80b9-417f8a04d823.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [153 x 43] intentionally omitted <==
Proven Ability In Life Sciences
August 5, 2025
To,
BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex, Dalal Street, Fort, Bandra (East), Mumbai – 400 001 Mumbai – 400 051 Scrip code: 512529 Symbol: SEQUENT
Subject: Intimation of Conference call
Dear Sir/ Madam,
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly note that the Company has scheduled a conference call with the Analysts/Investors on Monday, August 11, 2025, at 9.00 a.m. (I.S.T.) to discuss its Q1FY26 financial results. The Conference call details are enclosed herewith.
The above details are also available on the website of the Company in the Investors Section at: www.sequent.in
You are requested to take the same on record.
Yours faithfully,
For Sequent Scientific Limited
Vora Yoshita Digitally signed by Vora Yoshita Susmit Susmit Date: 2025.08.05 17:15:25 +05'30'
Yoshita Vora Company Secretary & Compliance Officer Encl: A/a
SeQuent Scientific Limited
Registered Office: 301, 3[rd] Floor, Dosti Pinnacle, Plot No. E7, Road No. 22, Wagle Industrial Estate, Thane (W), Mumbai - 400604, Maharashtra, India Tel No.: +91-22-4111-4777 I CIN: L99999MH1985PLC036685 Website : http://www.sequent.in I Email Id : [email protected]
==> picture [421 x 506] intentionally omitted <==
==> picture [161 x 40] intentionally omitted <==
SeQuent Q1FY26
Earnings Conference Call 11[th] August 2025, 9:00AM
Speakers
Mr. Rajaram Narayanan, MD & CEO, Sequent Scientific Dr. Hari Babu Bodepudi, WTD & CEO, Viyash Lifesciences Mr. Saurav Bhala, Chief Financial Officer, Sequent Scientific Mr. Ramakant Singani, Chief Financial Officer, Viyash Lifesciences Dial in For SeQuent Q1FY26 Conference call, Details: 11th August 2025, Time: 9:00 AM +91 22 6280 1263 Universal +91 22 7115 8213 Access DiamondPass (for early Click here registration)